Cite
HARVARD Citation
Okada, T. et al. (n.d.). Feasibility and safety of early initiation of a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor in patients with acute myocardial infarction undergoing primary PCI. European heart journal. p. . [Online].